MedTrace Logo

Fetal CPR at Term for Prediction of Adverse Neonatal Outcome in Pregnancies Complicated by GDM

NCT05852639 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 260

Last updated 2023-05-10

No results posted yet for this study

Summary

The goal of this observational study is to evaluate fetal cerebroplacental ratio at term and its relation to adverse neonatal outcome in patients with gestational diabetes. The main question\[s\] it aims to answer are:

* To evaluate the efficacy (sensitivity \& specificity) of fetal cerebroplacental ratio at term in prediction of adverse neonatal outcome in pregnancies complicated by gestational diabetes
* To evaluate the difference in fetal cerebroplacental ratio in patients treated by insulin \& those on metformin
* to evaluate the incidence of adverse neonatal outcome in patients treated by insulin \& those on metformin.

Participants will undergo ultrasound and doppler study at 37 weeks \& every two weeks thereafter till delivery. Neonatal assessment will be done after delivery to exclude adverse outcomes.

Conditions

  • Gestational Diabetes

Interventions

DEVICE

Ultrasound

Routine obstetric ultrasound will be done at term (at 37 weeks gestation): to confirm gestational age, assess fetal weight and amniotic fluid index and to exclude fetal anomalies.Doppler study and cerebroplacental ratio assessment will be done at 37 weeks gestation and repeated every two weeks

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Mariam Gabr · Cairo University

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-30
Primary Completion
2024-04-30
Completion
2024-04-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05852639 on ClinicalTrials.gov